Effects of Tissue Flossing on Pain and Functional Performance in Patients With Achilles Tendinopathy (NCT07519148) | Clinical Trial Compass
CompletedNot Applicable
Effects of Tissue Flossing on Pain and Functional Performance in Patients With Achilles Tendinopathy
Pakistan30 participantsStarted 2025-09-18
Plain-language summary
This study is a randomized controlled trial (RCT) investigating the effectiveness of tissue flossing as an adjunctive therapy for Achilles tendinopathy. Thirty participants, aged 20-45 years with a clinical diagnosis of Achilles tendinopathy (\>6 weeks), will be randomly assigned to one of two groups. The intervention group will receive a single session of tissue flossing (involving an elastic band wrapped from mid-calf to heel under moderate tension, followed by active ankle exercises) combined with conventional eccentric loading exercises. The control group will receive conventional eccentric loading exercises only. The primary outcome measures will be pain intensity, assessed using the Numeric Pain Rating Scale (NPRS); ankle range of motion, measured via the Weight-Bearing Lunge Test (WBLT); functional limitation, evaluated with the Lower Extremity Functional Scale (LEFS); and jump performance, measured by countermovement jump height using the My Jump Lab app. Assessments will be conducted at baseline, after the intervention session, and at a one-week follow-up. The study aims to determine if tissue flossing provides significant immediate and short-term improvements in pain and function, potentially offering a novel, low-cost supportive technique for rehabilitation.
Who can participate
Age range
20 Years – 45 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* · Adults aged 20-45 years.
* Clinically diagnosed with Achilles tendinopathy for more than 6 weeks.
* Ability to walk independently.
* Pain on palpation of the Achilles tendon.
* A pain score greater than 3/10 on the Numeric Pain Rating Scale (NPRS).
* Subjective reporting of pain located 2-6 cm above the tendon's insertion into the calcaneum (heel bone).
* A positive Painful Arc sign (pain localized to the tendon that moves with ankle motion).
* A Body Mass Index (BMI) between 18.5 and 29.9.
Exclusion Criteria:
* · Systemic inflammatory diseases (e.g., rheumatoid arthritis).
* A recent corticosteroid injection (e.g., within the last 3 months) or surgery related to the Achilles tendon.
* Diagnosed neurological deficits.
* Recent fractures in the lower limb.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Numeric Pain rating scale
Timeframe: From enrollment to the end of treatment at 1 week